Horti AG[au] - Search Results

Year	Number of Results
1995	1
1998	5
1999	3
2000	3
2001	1
2002	2
2003	4
2004	3
2005	3
2006	2
2007	4
2008	7
2009	4
2010	6
2011	3
2012	3
2013	4
2014	4
2015	6
2016	3
2017	3
2018	5
2019	4
2020	3
2021	2
2022	1

1

Opportunities in precision psychiatry using PET neuroimaging in psychosis.

Coughlin JM, Horti AG, Pomper MG. Coughlin JM, et al. Among authors: horti ag. Neurobiol Dis. 2019 Nov;131:104428. doi: 10.1016/j.nbd.2019.03.016. Epub 2019 Mar 20. Neurobiol Dis. 2019. PMID: 30904669 Free PMC article. Review.

2

First-in-human neuroimaging of soluble epoxide hydrolase using [¹⁸F]FNDP PET.

Coughlin JM, Slania S, Du Y, Shinehouse LK, Brosnan MK, Azad BB, Holt DP, Fan H, Lesniak WG, Minn I, Rowe SP, Dannals RF, Horti AG, Pomper MG. Coughlin JM, et al. Among authors: horti ag. Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3122-3128. doi: 10.1007/s00259-021-05231-4. Epub 2021 Feb 13. Eur J Nucl Med Mol Imaging. 2021. PMID: 33585963

3

¹⁸F-labeled radiotracers for in vivo imaging of DREADD with positron emission tomography.

Hu F, Morris PJ, Bonaventura J, Fan H, Mathews WB, Holt DP, Lam S, Boehm M, Dannals RF, Pomper MG, Michaelides M, Horti AG. Hu F, et al. Among authors: horti ag. Eur J Med Chem. 2021 Mar 5;213:113047. doi: 10.1016/j.ejmech.2020.113047. Epub 2020 Nov 25. Eur J Med Chem. 2021. PMID: 33280897 Free PMC article.

4

Development of [(18)F]ASEM, a specific radiotracer for quantification of the α7-nAChR with positron-emission tomography.

Horti AG. Horti AG. Biochem Pharmacol. 2015 Oct 15;97(4):566-575. doi: 10.1016/j.bcp.2015.07.030. Epub 2015 Jul 29. Biochem Pharmacol. 2015. PMID: 26232729 Free PMC article. Review.

5

Recent PET radioligands with optimal brain kinetics for imaging nicotinic acetylcholine receptors.

Horti AG, Kuwabara H, Holt DP, Dannals RF, Wong DF. Horti AG, et al. J Labelled Comp Radiopharm. 2013 Mar-Apr;56(3-4):159-66. doi: 10.1002/jlcr.3020. J Labelled Comp Radiopharm. 2013. PMID: 24285321 Review.

6

PET imaging of soluble epoxide hydrolase in non-human primate brain with [¹⁸F]FNDP.

Du Y, Minn I, Foss C, Lesniak WG, Hu F, Dannals RF, Pomper MG, Horti AG. Du Y, et al. Among authors: horti ag. EJNMMI Res. 2020 Jun 22;10(1):67. doi: 10.1186/s13550-020-00657-7. EJNMMI Res. 2020. PMID: 32572592 Free PMC article.

7

High-potency ligands for DREADD imaging and activation in rodents and monkeys.

Bonaventura J, Eldridge MAG, Hu F, Gomez JL, Sanchez-Soto M, Abramyan AM, Lam S, Boehm MA, Ruiz C, Farrell MR, Moreno A, Galal Faress IM, Andersen N, Lin JY, Moaddel R, Morris PJ, Shi L, Sibley DR, Mahler SV, Nabavi S, Pomper MG, Bonci A, Horti AG, Richmond BJ, Michaelides M. Bonaventura J, et al. Among authors: horti ag. Nat Commun. 2019 Oct 11;10(1):4627. doi: 10.1038/s41467-019-12236-z. Nat Commun. 2019. PMID: 31604917 Free PMC article.

8

Development of radioligands for in vivo imaging of type 1 cannabinoid receptors (CB1) in human brain.

Horti AG, Van Laere K. Horti AG, et al. Curr Pharm Des. 2008;14(31):3363-83. doi: 10.2174/138161208786549380. Curr Pharm Des. 2008. PMID: 19075713 Review.

9

Development of radioligands with optimized imaging properties for quantification of nicotinic acetylcholine receptors by positron emission tomography.

Horti AG, Gao Y, Kuwabara H, Dannals RF. Horti AG, et al. Life Sci. 2010 Apr 10;86(15-16):575-84. doi: 10.1016/j.lfs.2009.02.029. Epub 2009 Mar 18. Life Sci. 2010. PMID: 19303028 Free PMC article. Review.

10

PET/CT imaging of CSF1R in a mouse model of tuberculosis.

Foss CA, Ordonez AA, Naik R, Das D, Hall A, Wu Y, Dannals RF, Jain SK, Pomper MG, Horti AG. Foss CA, et al. Among authors: horti ag. Eur J Nucl Med Mol Imaging. 2022 Jun 17. doi: 10.1007/s00259-022-05862-1. Online ahead of print. Eur J Nucl Med Mol Imaging. 2022. PMID: 35713665

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results